Related Experiment Videos
Adjuvant systemic therapy in women with early-stage breast cancer at high risk for relapse
1Johns Hopkins Oncology Center, Baltimore, MD 21205.
Journal of the National Cancer Institute
|March 4, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage.
British journal of cancer·2015
Associations between breast cancer and rheumatoid arthritis among older-age women in the United States.
Journal of the National Cancer Institute·2026
NCI's clinical assay development program: supporting translation of biomarkers for cancer diagnosis.
Journal of the National Cancer Institute·2026
Changes In body composition and subsequent risk of relapse In childhood hodgkin lymphoma.
Journal of the National Cancer Institute·2026
Trends in bone health agent use and skeletal events in metastatic castration-resistant prostate cancer.
Journal of the National Cancer Institute·2026
Risk of second primary malignancies in older long-term survivors of breast, prostate, colon, and rectal cancer.
Journal of the National Cancer Institute·2026
Alignment with lifestyle recommendations and physical health in breast cancer survivors and women without cancer.
Journal of the National Cancer Institute·2026